Indcon Pharma Limited - Due diligence report

A 360° intelligence report on Indcon Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

2002-03-08 New Delhi, Delhi Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Indcon Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Indcon Pharma Limited is assessed as Low Risk with a Trust Score of 76/100. Indcon Pharma Limited is an active public limited indian non-government company incorporated in 2002, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Oct 2026 from the latest processed filings. Indcon Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
DIVYA MISRA 01234567 Director 01/04/2018 6 yrs Approved
PRABHAS NARAIN MISRA 01234567 Director 01/04/2018 6 yrs Approved
USHA RANI MISRA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • USHA RANI MISRA has DIN status "Disqualified by RoC u/s 164(2)".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 1 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Operating for 24+ years.
Distress signals & risk flags
Compliance score is weak (58/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 6 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 Sep 2009
Director appointed
DIVYA MISRA (Director)
08 Mar 2002
Incorporated
Registered with Roc Delhi I
Director appointed
PRABHAS NARAIN MISRA (Director)
Director appointed
USHA RANI MISRA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 1 financial year(s).
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Fateh Estates Private Limited U45201DL1997PTC087041 Delhi
Carex Mediciner Private Limited U24239DL2004PTC125731 Delhi
Cleandirty Narrative Lab Private Limited U63122DL2024PTC435802 Delhi
Ahl Cons India Private Limited U74899DL1985PTC021958 Delhi
Federation Of India Mineral Industries U74899DL1969NPL005064 New Delhi, Delhi
Trivium Education Services Private Limited U80222DL2010PTC203459 Delhi
Snapstream Media Private Limited U72900DL2003PTC118450 Delhi
Conservex Infomedia Private Limited U74999DL2018PTC331254 Delhi
Globe Civil Projects Limited U45202DL2002PLC115486 Delhi
Colormagix Digitalprint Private Limited U22220DL2008PTC179765 Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Indcon Pharma Limited before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Indcon Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Indcon Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Indcon Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Indcon Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Indcon Pharma Limited an active company?

Indcon Pharma Limited has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Indcon Pharma Limited financially healthy?

Indcon Pharma Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Indcon Pharma Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Indcon Pharma Limited?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Indcon Pharma Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Indcon Pharma Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Indcon Pharma Limited?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.